Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 12

1.

Binding Mechanism of the N-Terminal SH3 Domain of CrkII and Proline-Rich Motifs in cAbl.

Bhatt VS, Zeng D, Krieger I, Sacchettini JC, Cho JH.

Biophys J. 2016 Jun 21;110(12):2630-41. doi: 10.1016/j.bpj.2016.05.008.

PMID:
27332121
2.

Cyclophilin A promotes cell migration via the Abl-Crk signaling pathway.

Saleh T, Jankowski W, Sriram G, Rossi P, Shah S, Lee KB, Cruz LA, Rodriguez AJ, Birge RB, Kalodimos CG.

Nat Chem Biol. 2016 Feb;12(2):117-23. doi: 10.1038/nchembio.1981. Epub 2015 Dec 14.

3.

Reciprocal regulation of Abl kinase by Crk Y251 and Abi1 controls invasive phenotypes in glioblastoma.

Kumar S, Lu B, Dixit U, Hossain S, Liu Y, Li J, Hornbeck P, Zheng W, Sowalsky AG, Kotula L, Birge RB.

Oncotarget. 2015 Nov 10;6(35):37792-807. doi: 10.18632/oncotarget.6096.

4.

Contribution of Crk adaptor proteins to host cell and bacteria interactions.

Martinez-Quiles N, Feuerbacher LA, Benito-León M, Hardwidge PR.

Biomed Res Int. 2014;2014:372901. doi: 10.1155/2014/372901. Epub 2014 Nov 25. Review.

5.

The adaptor protein Crk in immune response.

Liu D.

Immunol Cell Biol. 2014 Jan;92(1):80-9. doi: 10.1038/icb.2013.64. Epub 2013 Oct 29. Review.

6.

Activation of abl family kinases in solid tumors.

Ganguly SS, Plattner R.

Genes Cancer. 2012 May;3(5-6):414-25. doi: 10.1177/1947601912458586.

7.

Crk and ABI1: binary molecular switches that regulate abl tyrosine kinase and signaling to the cytoskeleton.

Hossain S, Dubielecka PM, Sikorski AF, Birge RB, Kotula L.

Genes Cancer. 2012 May;3(5-6):402-13. doi: 10.1177/1947601912460051.

8.

Deciphering Phosphotyrosine-Dependent Signaling Networks in Cancer by SH2 Profiling.

Machida K, Khenkhar M, Nollau P.

Genes Cancer. 2012 May;3(5-6):353-61. doi: 10.1177/1947601912459048.

9.

Models of crk adaptor proteins in cancer.

Bell ES, Park M.

Genes Cancer. 2012 May;3(5-6):341-52. doi: 10.1177/1947601912459951.

10.

Functional mechanisms and roles of adaptor proteins in abl-regulated cytoskeletal actin dynamics.

Sato M, Maruoka M, Takeya T.

J Signal Transduct. 2012;2012:414913. doi: 10.1155/2012/414913. Epub 2012 May 17.

11.

SH3 domain tyrosine phosphorylation--sites, role and evolution.

Tatárová Z, Brábek J, Rösel D, Novotný M.

PLoS One. 2012;7(5):e36310. doi: 10.1371/journal.pone.0036310. Epub 2012 May 15.

12.

Domain organization differences explain Bcr-Abl's preference for CrkL over CrkII.

Jankowski W, Saleh T, Pai MT, Sriram G, Birge RB, Kalodimos CG.

Nat Chem Biol. 2012 May 13;8(6):590-6. doi: 10.1038/nchembio.954.

Items per page

Supplemental Content

Write to the Help Desk